Want to see IT:FDA full AI Analyst Report?
Fidia Spa (FDA) Ratios
Fidia Spa Ratios
IT:FDA's free cash flow for Q2 2026 was $-2.31M. For the 2026 fiscal year, IT:FDA's free cash flow was decreased by $-91.00K and operating cash flow was $-2.22M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.30 | 0.82 | 0.86 | 4.83 | 0.84 |
| Quick Ratio | 0.75 | 0.34 | 0.44 | 2.48 | 0.48 |
| Cash Ratio | 0.18 | 0.07 | 0.12 | 1.13 | 0.16 |
| Solvency Ratio | 0.12 | -0.32 | -0.00 | 1.69 | -0.04 |
| Operating Cash Flow Ratio | -0.27 | -0.18 | -0.19 | 0.18 | 0.02 |
| Short-Term Operating Cash Flow Coverage | -2.94 | -4.28 | -0.98 | 0.42 | 0.11 |
| Net Current Asset Value | $ -1.03M | $ -5.82M | $ -6.80M | $ 16.25M | $ -14.79M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.20 | 0.04 | 0.36 | 0.26 | 0.29 |
| Debt-to-Equity Ratio | 0.65 | 0.34 | 3.56 | 1.39 | -5.01 |
| Debt-to-Capital Ratio | 0.39 | 0.26 | 0.78 | 0.58 | 1.25 |
| Long-Term Debt-to-Capital Ratio | 0.33 | 0.10 | 0.28 | 0.00 | -1.47 |
| Financial Leverage Ratio | 3.27 | 9.61 | 10.00 | 5.39 | -17.35 |
| Debt Service Coverage Ratio | -0.45 | -5.65 | 0.08 | 3.45 | -0.20 |
| Interest Coverage Ratio | -2.52 | -16.55 | -2.70 | -13.46 | -6.85 |
| Debt to Market Cap | 0.29 | 0.01 | 0.01 | 0.00 | 0.01 |
| Interest Debt Per Share | 0.04 | 0.04 | 1.74 | 1.25 | 2.37 |
| Net Debt to EBITDA | -4.42 | 0.09 | 12.40 | 0.44 | -7.22 |
| Profitability Margins | |||||
| Gross Profit Margin | 24.18% | 74.17% | 66.88% | 5.94% | 65.14% |
| EBIT Margin | -5.58% | -50.25% | -2.15% | 24.17% | -12.28% |
| EBITDA Margin | -2.08% | -43.80% | 2.33% | 31.31% | -3.73% |
| Operating Profit Margin | -5.58% | -37.58% | -5.76% | -21.81% | -12.87% |
| Pretax Profit Margin | 4.04% | -52.52% | -4.28% | 22.77% | -13.67% |
| Net Profit Margin | 3.40% | -53.17% | -4.57% | 24.49% | -14.67% |
| Continuous Operations Profit Margin | 3.30% | -54.31% | -5.15% | 23.61% | -14.67% |
| Net Income Per EBT | 84.27% | 101.25% | 106.69% | 107.57% | 107.31% |
| EBT Per EBIT | -72.40% | 139.75% | 74.33% | -104.37% | 106.23% |
| Return on Assets (ROA) | 3.94% | -32.85% | -4.06% | 18.57% | -8.64% |
| Return on Equity (ROE) | 12.88% | -315.72% | -40.62% | 100.02% | 149.85% |
| Return on Capital Employed (ROCE) | -13.01% | -148.33% | -25.27% | -19.10% | -38.98% |
| Return on Invested Capital (ROIC) | -9.71% | -120.70% | -14.35% | -17.89% | -23.38% |
| Return on Tangible Assets | 4.07% | -33.41% | -4.18% | 19.17% | -8.99% |
| Earnings Yield | 5.65% | -5.91% | -0.21% | 0.57% | -0.36% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.75 | 3.94 | 5.21 | 3.45 | 2.78 |
| Payables Turnover | 4.53 | 0.80 | 1.58 | 4.16 | 0.74 |
| Inventory Turnover | 3.19 | 0.40 | 0.89 | 2.26 | 0.70 |
| Fixed Asset Turnover | 4.08 | 2.30 | 3.47 | 2.61 | 2.38 |
| Asset Turnover | 1.16 | 0.62 | 0.89 | 0.76 | 0.59 |
| Working Capital Turnover Ratio | -176.47 | -4.34 | 4.47 | 4.31 | -5.62 |
| Cash Conversion Cycle | 110.83 | 556.22 | 250.10 | 179.60 | 156.61 |
| Days of Sales Outstanding | 76.86 | 92.72 | 70.05 | 105.86 | 131.30 |
| Days of Inventory Outstanding | 114.56 | 919.41 | 411.61 | 161.38 | 518.18 |
| Days of Payables Outstanding | 80.59 | 455.91 | 231.56 | 87.64 | 492.88 |
| Operating Cycle | 191.42 | 1012.13 | 481.66 | 267.24 | 649.48 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.02 | -0.13 | -0.70 | 0.11 | 0.11 |
| Free Cash Flow Per Share | -0.03 | -0.13 | -0.77 | 0.07 | 0.10 |
| Dividend Paid and CapEx Coverage Ratio | -8.54 | -40.21 | -10.18 | 2.66 | 6.79 |
| Capital Expenditure Coverage Ratio | -8.54 | -40.21 | -10.18 | 2.66 | 6.79 |
| Operating Cash Flow Coverage Ratio | -0.69 | -4.28 | -0.42 | 0.10 | 0.05 |
| Operating Cash Flow to Sales Ratio | -0.12 | -0.25 | -0.17 | 0.03 | 0.02 |
| Free Cash Flow Yield | -22.07% | -2.83% | -0.86% | 0.05% | 0.05% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 17.75 | -17.11 | -472.04 | 174.84 | -279.34 |
| Price-to-Sales (P/S) Ratio | 0.60 | 9.00 | 21.57 | 42.82 | 40.97 |
| Price-to-Book (P/B) Ratio | 2.28 | 53.46 | 191.72 | 174.87 | -418.60 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -4.53 | -35.37 | -116.14 | 2107.65 | 1961.01 |
| Price-to-Operating Cash Flow Ratio | -5.06 | -36.25 | -127.55 | 1315.62 | 1672.23 |
| Price-to-Earnings Growth (PEG) Ratio | -0.17 | -0.41 | 3.87 | -0.77 | 6.75 |
| Enterprise Value Multiple | -33.36 | -20.47 | 937.38 | 137.18 | -1106.98 |
| Enterprise Value | 21.18M | 156.78M | 625.23M | 1.05B | 983.00M |
| EV to EBITDA | -33.36 | -20.47 | 937.38 | 137.18 | -1106.98 |
| EV to Sales | 0.69 | 8.97 | 21.86 | 42.96 | 41.24 |
| EV to Free Cash Flow | -5.22 | -35.22 | -117.70 | 2114.51 | 1973.89 |
| EV to Operating Cash Flow | -5.83 | -36.10 | -129.26 | 1319.90 | 1683.22 |
| Tangible Book Value Per Share | 0.05 | 0.07 | 0.36 | 3.84 | -0.65 |
| Shareholders’ Equity Per Share | 0.05 | 0.09 | 0.46 | 0.86 | -0.46 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.18 | -0.03 | -0.20 | -0.04 | -0.07 |
| Revenue Per Share | 0.20 | 0.51 | 4.13 | 3.51 | 4.66 |
| Net Income Per Share | 0.01 | -0.27 | -0.19 | 0.86 | -0.68 |
| Tax Burden | 0.84 | 1.01 | 1.07 | 1.08 | 1.07 |
| Interest Burden | -0.72 | 1.05 | 1.99 | 0.94 | 1.11 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.28 | 0.16 | 0.07 | 0.05 | 0.09 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -3.49 | 0.46 | 3.70 | 0.13 | -0.17 |
Currency in EUR